COMMUNIQUÉS West-GlobeNewswire

Dubai Sets the Stage for the Future of Healthcare with Next Generation Medicine 2026
07/10/2026
DUBAI, United Arab Emirates, Oct. 07, 2026 (GLOBE NEWSWIRE) -- As Dubai rapidly solidifies its position as a global epicentre for preventive care, healthcare innovation, and health span extension, the Next Generation [...]
MUVON Therapeutics Reports Positive 12-Month Phase 2 Follow-up Data Confirming Durable Efficacy of its First-in-Class Muscle Regeneration Therapy in Stress Urinary Incontinence
07/10/2026
Zurich, Switzerland, October 7, 2026 – MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive 12-month interim results from the Long-Term Follow-Up Study of the Phase 2 clinical trial SUISSE- [...]
ITM and Lumara Bio to Announce New Data for ¹⁷⁷Lu-edotreotide (ITM-11) and Ga-DPI-4452 at EANM 2026
07/10/2026
Data will be presented in two top-rated oral presentations Meet the Expert session offers insights into Actinium-225 production Garching / Munich, October 7 , 2026 — ITM Isotope Technologies Munich SE (ITM) , a leading [...]
Teladoc Health Expands Solo Connected Care Platform with AI-Powered Capabilities to Help Hospitals Scale Smarter Care Delivery
07/10/2026
New SoloVitals and SoloScribe capabilities bring contactless vitals and ambient documentation directly into clinical workflows NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader [...]
Une nouvelle étude révèle qu’une majorité de jeunes hommes passent un temps excessif sur les médias sociaux, ce qui peut avoir des répercussions importantes sur leur santé mentale
07/10/2026
VANCOUVER, Colombie-Britannique, 07 oct. 2026 (GLOBE NEWSWIRE) -- Une recherche récente révèle que plus de la moitié des jeunes hommes canadiens passent plus de trois heures par jour sur les médias sociaux, ce qui [...]
New study finds a majority of younger men spend an unhealthy amount of time on social media, significantly impacting their mental health
07/10/2026
VANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Latest research shows more than half of young Canadian men spend over 3 hours a day on social media which significantly increases their risk of poor mental [...]
SparkLabs Taiwan Announces Professor Shan-Qun Huang’s Planned Return to Taiwan to Support International Capital Cooperation and Financial Talent Development
07/10/2026
TAIPEI, Taiwan, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Following the completion of a recent phase of overseas investment research projects, Professor Shan-Chun Huang is planning to gradually shift the focus of his next stage [...]
Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia
07/10/2026
First patient enrolled in cohort combining bexobrutideg with venetoclax Initial cohort to focus on relapsed/refractory CLL, with potential expansion to first-line CLL Strategy includes evaluation of bexobrutideg given [...]
Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day
07/10/2026
Licaminlimab genotype-based precision medicine approach for TNFR1-mediated dry eye disease in PREDICT-1 registrational symptoms trial on track for topline readout around year-end ZUG, Switzerland, October 7, 2026 -- [...]
125,000 Orion Corporation A shares converted into B shares
07/10/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 7 OCTOBER 2026 at 9.00 EEST 125,000 Orion Corporation A shares converted into B shares In accordance with [...]
Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day
07/10/2026
Licaminlimab genotype-based precision medicine approach for TNFR1-mediated dry eye disease in PREDICT-1 registrational symptoms trial on track for topline readout around year-end ZUG, Switzerland, October 7, 2026 -- [...]
PulseSight presents PST-611 Phase I new early clinical efficacy data at EURETINA, offering a potential breakthrough approach to treat Dry AMD/Geographic Atrophy
07/10/2026
PARIS, Oct. 07, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical-stage biotech company developing disruptive non-viral vectorized gene therapies with minimally invasive delivery technology [...]
Virbac : Déclaration d'actions et de droits de vote 09/2026
07/10/2026
DÉCLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Virbac : Declaration of the number of shares et voting rights 09/2026
07/10/2026
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
BIO-Europe C-Suite Survey: Biopharma dealmaking set to accelerate, but investor caution still caps ambition
07/10/2026
75% of biopharma leaders expect partnering and M&A appetite to increase over the next 12 months, none expect a decline 69% expect access to capital to improve, yet 79% identify investor risk aversion as the biggest [...]
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
07/10/2026
SAN CARLOS, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the pricing of concurrent underwritten public offerings of 7,412,500 [...]
OGRD Alliance Advances PLPC Multi-Asset Platform Following APHELAR Milestone, Expanding Licensing and Strategic Capital Frameworks
07/10/2026
DUBAI, United Arab Emirates, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Microdomain Science connects differentiated assets across personalized immuno-oncology, acellular biotechnology, MedTech and precision nutrition as OGRD [...]
Ozari Health Launches Ozari One: Compounded Tirzepatide Online for $125 a Month, Same Price at Every Dose
06/10/2026
The LegitScript-certified telehealth platform's new plan bills $375 every three months for compounded tirzepatide with B12, filled by one of three named US-licensed 503A compounding pharmacies, with the provider visit [...]
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/10/2026
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer [...]

Pages